VANECK BIONIC ENGINEERING UCITS ETF - USD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | -.--% |
Investment objective
VanEck?s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 330.4 AUD | -2.51% | +3.14% | +10.62% | -.--% | ||
| 291.2 CHF | -1.89% | +7.73% | +6.12% | -.--% | ||
| 121.4 CHF | -1.70% | +1.84% | -10.44% | -.--% | ||
| 335 DKK | +1.21% | +4.56% | +13.18% | -.--% | ||
| 85.92 USD | +0.33% | +3.72% | +4.30% | -.--% | ||
| 34.36 EUR | -0.09% | -0.32% | +9.64% | -.--% | ||
| 121,000 KRW | -1.79% | +0.58% | -7.63% | -.--% | ||
| 1.93 HKD | +2.12% | +3.76% | -17.87% | -.--% | ||
| 7.08 HKD | -0.28% | +0.43% | -15.91% | -.--% | ||
| 11.05 USD | -3.32% | -4.08% | -26.87% | -.--% | ||
More news
In partnership with
Description
| IE0005TF96I9 | |
|---|---|
| Total Expense Ratio | 0.55% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS Global Bionic Healthcare ESG Index (NTR) - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2022-11-30
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 6 M€ |
|---|---|
| AuM 1M | 6 M€ |
| AuM 3 months | 6 M€ |
| AuM 6 months | 4 M€ |
| AuM 12 months | 5 M€ |
- Stock Market
- ETF
- CYBO ETF
